Dr. Clay Siegall, Ph.D. offers a great new hope for cancer patients.

Dr. Clay Siegall, Ph.D. developed an intense enthusiasm for genetics early on in his journey to become the career scientific researcher he is today. He earned a Bachelor of Science Degree in Zoology from the University of Maryland and his Ph.D. in Genetics from George Washington University. From there he went on to immerse himself further when he went to work for the National Cancer Institute of Health during the years 1988 to 1991 followed by a six year stint at the Bristol-Meyers Squibb Pharmaceutical Research Institute from 1991 to 1997. Having gained enormously more knowledge and training greatly focused on cancer treatment therapies; he went on to become the co-founder, Chief Executive Officer, and Chairman of the Board of the currently globally recognized biotechnology corporation, Seattle Genetics, that was incorporated in 1998.

 

As the Co-founder and Chief Executive Officer of Seattle Genetics, Dr. Clay Siegall, Ph.D. demonstrated an unparalleled passion for helping patients who had the misfortune of being diagnosed with cancer. He created and environment receptive to exploratory minds committed to meticulous research and disciplined practices in the search of innovative scientific discoveries related to cancer treatments. The focuses of this endeavor lead to the groundbreaking discovery of antibody drug conjugates or ADCs.

 

Since the discovery of ADCs, Dr. Clay Siegall, Ph.D. has broadened the horizons of Seattle Genetics to include even greater discoveries and applications in conjunctive collaboration involving other biotechnology and pharmaceutical companies. ADCs have quickly inspired a variety of new cancer treatments that span a widening spectrum of cancers in over sixty countries.

 

In addition to the accomplishments of Seattle Genetics gained under the leadership and guidance of Dr. Clay Siegall, Ph.D., he has authored over seventy publications and secured fifteen product patents to date. He has been recognized as the recipient of the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year and the 2013 University of Maryland Alumnus of the Year for Computer, Math, and Natural Sciences awards. He has enthralled internet and written publication media outlets throughout the world as they anticipate the next wave of greatness from this extraordinary mind.